- Home
- BLTE
BLTE
Belite Bio Inc
as 11-21-2024 4:00pm EST
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 2.1B | IPO Year: | 2022 |
| Target Price: | $89.00 | AVG Volume (30 days): | 107.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.11 | EPS Growth: | N/A |
| 52 Week Low/High: | $31.01 - $86.53 | Next Earning Date: | 11-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Belite Bio Inc News
BLTE Breaking Stock News: Dive into BLTE Ticker-Specific Updates for Smart Investing
MT Newswires
10 days ago
Belite Bio Q3 Net Loss Narrows
GlobeNewswire
10 days ago
Belite Bio Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
16 days ago
Belite Bio to Host Webcast on November 12, 2024, to Discuss Third Quarter 2024 Financial Results
MT Newswires
18 days ago
Belite Bio Raises $28.8 Million After Warrants Exercised
GlobeNewswire
18 days ago
Belite Bio Announces Exercise of Warrants for US$28.75 Million Gross Proceeds
GlobeNewswire
a month ago
Belite Bio Announces Presentations at the American Academy of Ophthalmology 2024 Annual Meeting
GlobeNewswire
a month ago
Belite Bio to Participate in the Maxim Group 2024 Healthcare Virtual Summit
GlobeNewswire
2 months ago
Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
Compare BLTE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "BLTE Belite Bio Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.